Conference: Breakout Sessions

Track: Global Biotechnology Issues

Date: Wednesday May 5, 2010

Time: 8:00 AM - 9:30 AM

Location: McCormick Place, Chicago

Room: S403B

Description: Drug counterfeiting is as dangerous to patients as it is damaging to profits—and the market is only growing. It is estimated that within the next 18 months, counterfeit drugs will hold 14 percent of the total market, creating its own $75 billion industry. Biotech is not immune. By gaining key perspectives from stakeholders, we will discuss the relevance of anti-counterfeiting to the biotech community from early-stage to established biotechs, and practical options to respond to the threat. As we move toward health care reform, there is a need for increased communication and collaboration to find affordable and workable solutions. Panelists will discuss the challenges, opportunities and responsibilities from different viewpoints, highlighting key issues to be addressed by the industry.

Program: Hot Topic

Objectives:
1. Understanding the commercial impact of counterfeiting, in terms of revenue, brand protection and acquisition value

2. Outline different approaches to address the challenges of integrating strategic, low-cost authentication technologies.

3. “Bridging the gap” between early-stage and big biotech – where in the development cycle to address counterfeiting issues